n Cardiovascular Journal of South Africa - Cardio news




Extracted from text ... 72 CARDIOVASCULAR JOURNAL OF SOUTH AFRICA Vol 16, No. 1, January/February 2005 Cardio News Amlodipine now more affordable Pharma Dynamics is pleased to offer South Africans a cost-effective choice of one of the world's leading cardiovascular medications. The launch of Amloc combines the therapeutic benefit of amlodipine with significant cost savings, to unlock the treatment of hypertension and angina. Amloc is clinically proven to deliver bio-equivalent plasma levels of amlodipine, compared to the originator's product. In addition, Amloc is supported by substantial clinical evidence of its comparable efficacy, safety and tolerability with the originator's amlodipine. This evidence lies at the ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error